Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 38

1.

ASHP Guidelines on Preventing Diversion of Controlled Substances.

Brummond PW, Chen DF, Churchill WW, Clark JS, Dillon KR, Dumitru D, Eschenbacher L, Fera T, Fortier CR, Gullickson KK, Jurakovich K, Kent S, Keonavong J, Marchese C, Meyer T, Murdaugh LB, Ogden RK Jr, O'Neal BC, Rough S, Saenz R, Smith JS.

Am J Health Syst Pharm. 2017 Mar 1;74(5):325-348. doi: 10.2146/ajhp160919. Epub 2017 Jan 4. No abstract available.

PMID:
28052859
2.

Leveraging drug-utilization and external benchmarking data to drive change in prescribing behaviors.

O'Neal BC, Couldry RJ, Wilkinson ST, Cannella CA, Williams CB, Scott LA, Simpson SQ.

Am J Health Syst Pharm. 2012 Nov 1;69(21):1916-22. doi: 10.2146/ajhp110429.

PMID:
23111677
3.

New approaches to bedside monitoring in stroke.

Cyrous A, O'Neal B, Freeman WD.

Expert Rev Neurother. 2012 Aug;12(8):915-28. Review.

PMID:
23002936
4.

Validation of frontal near-infrared spectroscopy as noninvasive bedside monitoring for regional cerebral blood flow in brain-injured patients.

Taussky P, O'Neal B, Daugherty WP, Luke S, Thorpe D, Pooley RA, Evans C, Hanel RA, Freeman WD.

Neurosurg Focus. 2012 Feb;32(2):E2. doi: 10.3171/2011.12.FOCUS11280.

PMID:
22296679
5.

The nonpharmacist business manager: key qualifications and skills for success.

Granko RP, O'Neal BC, Fanikos J, Cohen BA, Cromes NV, Hicks DW, Thompson B, Poppe LB.

Am J Health Syst Pharm. 2011 Oct 1;68(19):1779-82. doi: 10.2146/ajhp100675. No abstract available.

PMID:
21930636
6.

Compliance with recommendations for prevention and detection of controlled-substance diversion in hospitals.

McClure SR, O'Neal BC, Grauer D, Couldry RJ, King AR.

Am J Health Syst Pharm. 2011 Apr 15;68(8):689-94. doi: 10.2146/ajhp100212.

PMID:
21460174
7.

Safety of symptom-limited cardiopulmonary exercise testing in patients with chronic heart failure due to severe left ventricular systolic dysfunction.

Keteyian SJ, Isaac D, Thadani U, Roy BA, Bensimhon DR, McKelvie R, Russell SD, Hellkamp AS, Kraus WE; HF-ACTION Investigators..

Am Heart J. 2009 Oct;158(4 Suppl):S72-7. doi: 10.1016/j.ahj.2009.07.014.

8.

Outcomes, health policy, and managed care: relationships between patient-reported outcome measures and clinical measures in outpatients with heart failure.

Flynn KE, Lin L, Ellis SJ, Russell SD, Spertus JA, Whellan DJ, Piña IL, Fine LJ, Schulman KA, Weinfurt KP; HF-ACTION Investigators..

Am Heart J. 2009 Oct;158(4 Suppl):S64-71. doi: 10.1016/j.ahj.2009.07.010.

9.

Relationship of age and exercise performance in patients with heart failure: the HF-ACTION study.

Forman DE, Clare R, Kitzman DW, Ellis SJ, Fleg JL, Chiara T, Fletcher G, Kraus WE; HF-ACTION Investigators..

Am Heart J. 2009 Oct;158(4 Suppl):S6-S15. doi: 10.1016/j.ahj.2009.07.018.

10.

Myocardial perfusion, function, and dyssynchrony in patients with heart failure: baseline results from the single-photon emission computed tomography imaging ancillary study of the Heart Failure and A Controlled Trial Investigating Outcomes of Exercise TraiNing (HF-ACTION) Trial.

Atchley AE, Kitzman DW, Whellan DJ, Iskandrian AE, Ellis SJ, Pagnanelli RA, Kao A, Abdul-Nour K, O'Connor CM, Ewald G, Kraus WE, Borges-Neto S; HF-ACTION Investigators..

Am Heart J. 2009 Oct;158(4 Suppl):S53-63. doi: 10.1016/j.ahj.2009.07.009.

11.

Relationship of Doppler-Echocardiographic left ventricular diastolic function to exercise performance in systolic heart failure: the HF-ACTION study.

Gardin JM, Leifer ES, Fleg JL, Whellan D, Kokkinos P, Leblanc MH, Wolfel E, Kitzman DW; HF-ACTION Investigators..

Am Heart J. 2009 Oct;158(4 Suppl):S45-52. doi: 10.1016/j.ahj.2009.07.015.

12.

N-terminal pro-brain natriuretic peptide and exercise capacity in chronic heart failure: data from the Heart Failure and a Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION) study.

Felker GM, Whellan D, Kraus WE, Clare R, Zannad F, Donahue M, Adams K, McKelvie R, Piña IL, O'Connor CM; HF-ACTION Investigators..

Am Heart J. 2009 Oct;158(4 Suppl):S37-44. doi: 10.1016/j.ahj.2009.07.011.

13.

The relationship between body mass index and cardiopulmonary exercise testing in chronic systolic heart failure.

Horwich TB, Leifer ES, Brawner CA, Fitz-Gerald MB, Fonarow GC; HF-ACTION Investigators..

Am Heart J. 2009 Oct;158(4 Suppl):S31-6. doi: 10.1016/j.ahj.2009.07.016.

14.

New York Heart Association functional class predicts exercise parameters in the current era.

Russell SD, Saval MA, Robbins JL, Ellestad MH, Gottlieb SS, Handberg EM, Zhou Y, Chandler B; HF-ACTION Investigators..

Am Heart J. 2009 Oct;158(4 Suppl):S24-30. doi: 10.1016/j.ahj.2009.07.017.

15.

Baseline differences in the HF-ACTION trial by sex.

Piña IL, Kokkinos P, Kao A, Bittner V, Saval M, Clare B, Goldberg L, Johnson M, Swank A, Ventura H, Moe G, Fitz-Gerald M, Ellis SJ, Vest M, Cooper L, Whellan D; HF-ACTION Investigators..

Am Heart J. 2009 Oct;158(4 Suppl):S16-23. doi: 10.1016/j.ahj.2009.07.012.

16.

Understanding heart failure through the HF-ACTION baseline characteristics.

O'Connor CM, Whellan DJ; HF-ACTION Investigators..

Am Heart J. 2009 Oct;158(4 Suppl):S1-5. doi: 10.1016/j.ahj.2009.07.013. No abstract available.

PMID:
19782783
17.

Telepharmacy and bar-code technology in an i.v. chemotherapy admixture area.

O'Neal BC, Worden JC, Couldry RJ.

Am J Health Syst Pharm. 2009 Jul 1;66(13):1211-7. doi: 10.2146/ajhp080388.

PMID:
19535660
18.

Effects of exercise training on health status in patients with chronic heart failure: HF-ACTION randomized controlled trial.

Flynn KE, Piña IL, Whellan DJ, Lin L, Blumenthal JA, Ellis SJ, Fine LJ, Howlett JG, Keteyian SJ, Kitzman DW, Kraus WE, Miller NH, Schulman KA, Spertus JA, O'Connor CM, Weinfurt KP; HF-ACTION Investigators..

JAMA. 2009 Apr 8;301(14):1451-9. doi: 10.1001/jama.2009.457. Erratum in: JAMA. 2009 Dec 2;302(21):2322.

19.

Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial.

O'Connor CM, Whellan DJ, Lee KL, Keteyian SJ, Cooper LS, Ellis SJ, Leifer ES, Kraus WE, Kitzman DW, Blumenthal JA, Rendall DS, Miller NH, Fleg JL, Schulman KA, McKelvie RS, Zannad F, Piña IL; HF-ACTION Investigators..

JAMA. 2009 Apr 8;301(14):1439-50. doi: 10.1001/jama.2009.454.

20.

Outcomes of Staphylococcus aureus infection in hemodialysis-dependent patients.

Li Y, Friedman JY, O'Neal BF, Hohenboken MJ, Griffiths RI, Stryjewski ME, Middleton JP, Schulman KA, Inrig JK, Fowler VG Jr, Reed SD.

Clin J Am Soc Nephrol. 2009 Feb;4(2):428-34. doi: 10.2215/CJN.03760708. Epub 2008 Dec 31.

Supplemental Content

Loading ...
Support Center